c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5157-5167

  Otsuka, Toshiyuki ^a   Takayama, Hisashi ^a,d   Sharp, Richard ^a   Celli, Giulia ^a   LaRochelle, William J ^a   Bottaro, Donald P ^a   Ellmore, Nelson ^a   Vieira, Wilfred ^a   Owens, Jennie W ^b   Anver, Miriam ^c   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SCATTER FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CARCINOGENESIS; GENE EXPRESSION; HISTOPATHOLOGY; MELANOCYTE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; MALE; MELANOCYTES; MELANOMA, AMELANOTIC; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 0032533495     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (95)

1. Rigel, D. S., Kopf, A. W., and Friedman, R. J. The rate of malignant melanoma in the U. S.: are we making an impact? J. Am. Acad. Dermatol., 17: 1050-1053, 1987.
2. Rigel, D. S., Friedman, R. J., and Kopf, A. W. Lifetime risk for development of skin cancer in the U. S. population: current estimate is now 1 in 5. J. Am. Acad. Dermatol., 35: 1012-1013, 1996.
3. Herlyn, M. Molecular and Cellular Biology for Melanoma, pp. 1-102. Austin, TX: R. G. Landes Co., 1993.
4. Welch, D. R., and Goldberg, S. F. Molecular mechanisms controlling human melanoma progression and metastasis. Pathobiology, 65: 311-330, 1997.
5. Kusewitt, D. F., and Ley, R. D. Animal models of melanoma. Cancer Surv., 26: 35-70, 1996.
6. Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., and DePinho, R. A. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. Genes Dev., 11: 2822-2834, 1997.
7. Gherardi, E., and Stoker, M. Hepatocyte growth factor-scatter factor: mitogen, motogen, and Met. Cancer Cells, 3: 227-232, 1991.
8. Brinkmann, V., Foroutan, H., Sachs, M., Weidner, K. M., and Birchmeier, W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J. Cell Biol., 131: 1573-1586, 1995.
9. Zarnegar, R., and Michalopoulos, G. K. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol., 129: 1177-1180, 1995.
10. Rubin, J. S., Chan, A. M., Bottaro, D. P., Burgess, W. H., Taylor, W. G., Cech, A. C., Hirschfield, D. W., Wong, J., Miki, T., Finch, P. W., and Aaronson, S. A. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc. Natl. Acad. Sci. USA, 88: 415-419, 1991.
11. Matsumoto, K., Tajima, H., and Nakamura, T. Hepatocyte growth factor is a potent stimulator of human melanocyte DNA synthesis and growth. Biochem. Biophys. Res. Commun., 176: 45-51, 1991.
12. Iyer, A., Kmiecik, T. E., Park, M., Daar, I., Blair, D., Dunn, K. J., Sutrave, P., Ihle, J. N., Bodescot, M., and Vande Woude, G. F. Structure, tissue-specific expression, and transforming activity of the mouse met protooncogene. Cell Growth Differ., 1: 87-95, 1990.
13. Sonnenberg, E., Meyer, D., Weidner, K. M., and Birchmeier, C. Scatter factor/ hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell. Biol., 123: 223-235, 1993.
14. Tsarfaty, I., Rong, S., Resau, J. H., Rulong, S., Pinto da Silva, P., and Vande Woude, G. F. Met mediated signaling in mesenchymal to epithelial cell conversion. Science (Washington DC), 263: 98-101, 1994.
15. Schmidt, C., Bladt, F., Goedecke, S., Brinkmann, V., Zschiesche, W., Sharpe, M., Gherardi, E., and Birchmeier, C. Scatter factor/hepatocyte growth factor is essential for liver development. Nature (Lond.), 373: 699-702, 1995.
16. Uehara, Y., Minowa, O., Mori, C., Shiota, K., Kuno, J., Noda, T., and Kitamura, N. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/ scatter factor. Nature (Lond.), 373: 702-705, 1995.
17. Bladt, F., Rlethmacher, D., Isenmann, S., Aguzzi, A., and Birchmeier, C. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature (Lond.), 376: 768-771, 1995.
18. Park, M., Dean, M., Cooper, C. S., Schmidt, M., O'Brien, S. J., Blair, D. G., and Vande Woude, G. F. Mechanism of met oncogene activation. Cell, 45: 895-904, 1986.
19. Dean, M., Park, M., and Vande Woude, G. F. Characterization of the rearranged tpr-met oncogene breakpoint. Mol. Cell Biol., 7: 921-924, 1987.
20. Prat, M., Narsimhan, R. P., Crepaldi, T., Nicotra, M. R., Natali, P. G., and Comoglio, P. M. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer, 49: 323-328, 1991.
21. Di Renzo, M. F., Olivero, M., Ferro, S., Prat, M., Bongarzone, I., Pilotti, S., Belfiore, A., Constantio, A., Vigneri, R., Pierotti, M. A., and Comoglio, P. M. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas. Oncogene, 7: 2549-2553, 1992.
22. Rong, S., Jerrers, M., Resau, J. H., Tsarfaty, I., Oscarsson, M., and Vande Woude, G. F. Met expression and sarcoma tumorigenicity. Cancer Res., 53: 5355-5360, 1993.
23. Tuck, A. B., Park, M., Sterns, E. E., Boag, A., and Elliott, B. E. Coexpression of hepatocytes growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol., 148: 225-232, 1996.
24. Rong, S., Donehower, L. A., Hansen, M. F., Strong, L., Tainsky, M., Jeffers, M., Resau, J. H., Hudson, E., Tsarfaty, I., and Vande Woude, G. F. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res., 55: 1963-1970, 1995.
25. Ferracini, R., Olivero, M., Di Renzo, M. F., Martano, M., De Giovanni, C., Nanni, P., Basso, G., Scotlandi, K., Lollini, P-L., and Comoglio, P. M. Retroviral expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene, 11: 1697-1705, 1996.
26. Natali, P. G., Nicotra, M. R., Di Renzo, M. R., Prat, M., Bigotti, A., Cavaliere, R., and Comoglio, P. M. Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer, 68: 746-750, 1993.
27. Rong, S., Oskarsson, M., Faletto, D. L., Tsarfaty, I., Resau, J., Nakamura, T., Rosen, E., Hopkins, R., and Vande Woude, G. F. Tumorigenesis induced by coexpression of human hepatocyte growth factor and the human met protooncogene leads to high levels of expression of the ligand and receptor. Cell Growth Differ., 4: 563-569, 1993.
28. Ferracini, R., Di Renzo, M. F., Scotlandi, K., Baldini, N., Olivero, M., Lollini, P., Cremona, O., Campanacci, M., and Comoglio, P. M. The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit. Oncogene, 10: 739-749, 1995.
29. Rong, S., Bodescot, M., Blair, D., Dunn, J., Nakamura, T., Mizuno, K., Park, M., Chan, A., Aaronson, S., and Vande Woude, G. F. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol. Cell. Biol., 12: 5152-5158, 1992.
30. Kanda, H., Tajima, H., Lee, G-H., Nomura, K., Ohtake, K., Matsumoto, K., Nakamura, T., and Kitagawa, T. Hepatocyte growth factor transforms immortalized mouse liver epithelial cells. Oncogene, 8: 3047-3053, 1993.
31. Bellusci, S., Moens, G., Gaudino, G., Comoglio, P., Nakamura, T., Thiery, J-P., and Jouanneau, J. Creation of a hepatocyte growth factor/scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene, 9: 1091-1099, 1994.
32. Jeffers, M., Rong, S., and Vande Woude, G. F. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J. Mol. Med., 74: 505-513, 1996.
33. Matsumoto K., and Nakamura, T. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem., 119: 591-600, 1996.
34. Rosen, E. M., Lamszus, K., Laterra, J., Polverini, P. J., Rubin, J. S., and Goldberg, I. D. HGF/SF in angiogenesis. Ciba Found. Symp., 212: 215-226, 1997.
35. Rong, S., Segal, S., Anver, M., Resau, J. H., and Vande Woude, G. F. Invasiveness and metastasis of NIH/3T3 cells induced by Met-HGF/SF autocrine stimulation. Proc. Natl. Acad. Sci. USA, 91: 4731-4735, 1994.
36. Jeffers, M., Rong, S., Anver, M., and Vande Woude, G. F. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/ metastatic phenotype in C127 cells. Oncogene, 13: 853-861, 1996.
37. Takayama, H., LaRochelle, W. J., Anver, M., Bockman, D. E., and Merlino, G. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc. Natl. Acad. Sci. USA, 93: 5866-5871, 1996.
38. Sakata, H., Takayama, H., Sharp, R., Rubin, J. S., Merlino, G., and LaRochelle, W. J. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development and tumor formation in transgenic mouse livers. Cell Growth Differ., 7: 1513-1523, 1996.
39. Takayama H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., and Merlino, G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA, 94: 701-706, 1997.
40. Palmiter, R. D., Sandgren, E. P., Koeller, D. M., and Brinster, R. L. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Mol. Cell. Biol., 13: 5266-5275, 1993.
41. Jiménez, M., Kameyama, K., Maloy, W. L., Tomita, Y., and Hearing, V. J. Mammalian tyrosinase: biosynthesis, processing and modulation by melanocyte stimulating hormone. Proc. Natl. Acad. Sci. USA, 85: 3830-3834, 1988.
42. Jiménez, M., Tsukamoto, K., and Hearing, V. J. Tyrosinase from two different loci are expressed by normal and by transformed melanocytes. J. Biol. Chem., 266: 1147-1156, 1991.
43. Kobayashi, T., Urabe, K., Orlow, S. J., Higashi, K., Imokawa, G., Kwon, B. S., Potterf, B., and Hearing, V. J. The Pmel 17/silver locus protein: characterization and investigation of its melanogenic function. J. Biol. Chem., 269: 29198-29205, 1994.
44. Jhappan, C., Stahle, C., Harkins, R. N., Fausto, N., Smith, G. H., and Merlino, G. T. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61: 1137-1146, 1990.
45. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N. A., Copeland, N. G., Suda, T., and Nagata, S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell, 76: 969-976, 1994.
46. Rubin, J. S., Osada, H., Finch, P. W., Taylor, W. G., Rudikoff, S., and Aaronson, S. A. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc. Natl. Acad. Sci. USA, 86: 802-806, 1989.
47. Yokoyama, T., Silversides, D. W., Waymire, K. G., Kwon, B. S., Takeuchi, T., and Overbeek, P. A. Conserved cysteine to serine mutation in tyrosinase is responsible for the classical albino mutation in laboratory mice. Nucleic Acids Res., 18: 7293-7298, 1990.
48. Yoshitomi, K., Elwell, M. R., and Boorman, G. A. Pathology and incidence of amelanotic melanomas of the skin in F-344/N rats. Toxicol. Pathol., 23: 16-25, 1995.
49. Chan, A. M-L., Rubin, J. S., Bottaro, D. P., Hirschfield, D. W., Chedid, M., and Aaronson, S. A. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science (Washington DC), 254: 1382-1385, 1991.
50. Miyazawa, K., Kitamura, A., Naka, D., and Kitamura, N. An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur. J. Biochem., 197: 15-22, 1991.
51. Hartmann, G., Naldini, L., Weidner, K. M., Sachs, M., Vigna, E., Comoglio, P. M., and Birchmeier, W. A functional domain in the heavy chain of scatter factor/ hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but not mitogenesis. Proc. Natl. Acad. Sci. USA, 89: 11574-11578, 1992.
52. Halaban, R. Growth factors and tyrosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Rev., 10: 129-140, 1991.
53. Halaban, R. Signal transduction in normal and malignant melanocytes. Pigment Cell Res., 7: 89-95, 1994.
54. Halaban, R., Ghosh, S., and Baird, A. bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell. Dev. Biol., 23: 47-52, 1987.
55. Dotto, G. P., Moellmann, G., Ghosh, S., Edwards, M., and Halaban, R. Transformation of murine melanocytes by basic fibroblast growth factor cDNA and oncogenes and selective suppression of the transformed phenotype in a reconstituted cutaneous environment. J. Cell Biol., 109: 3115-3128, 1989.
56. Hahne, M., Rimoldi, D., Schroter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., Cerottini, J-C., and Tschopp, J. Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape. Science (Washington DC), 274: 1363-1366, 1996.
57. Halaban, R., Rubin, J. S., Funasaka, Y., Cobb, M., Boulton, T., Faletto, D., Rosen, E., Chan, A., Yoko, K., White W., Cook, C., and Moellmann, G. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene, 7: 2195-2206, 1992.
58. Saitoh, K., Takahashi, H., Sawada, N., and Parsons, P. G. Detection of the c-met proto-oncogene product in normal skin and tumours of melanocytic origin. J. Pathol., 174: 191-199, 1994.
59. Gutman, M., Singh, R. K., Radinsky, R., and Bar-Eli, M. Intertumoral heterogeneity of receptor-tyrosine kinases expression in human melanoma cell lines with different metastatic capabilities. Anticancer Res., 14: 1759-1765, 1994.
60. Rusciano, D., Lorenzoni, P., and Burger, M. M. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization. Oncogene, 11: 1979-1987, 1995.
61. Hendrix, M. J. C., Seftor, E. A., Seftor, R. E. B., Kirschmann, D. A., Gardner, L. M., Boldt, H. C., Meyer, M., Pe'er, J., and Folberg, R. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF). Am. J. Pathol., 152: 855-863, 1998.
62. Schmidt, L., Duh, F. M., Chen, F., Kishida, T., Glenn, G., Choyke, P., Scherer, S. W., Zhuang, Z., Lubensky, I., Dean, M., Allikmets, R., Chidambaram, A., Bergerheim, U. R., Feltis, J. T., Casadevall, C., Zamarron, A., Bernues, M., Richard, S., Lips, C. J., Walther, M. M., Tsui, L. C., Geil, L., Orcutt, M. L., Stackhouse, T., Lipan, J., Slife, L., Brauch, H., Decker, J., Niehans, G., Hughson, M. D., Moch, H., Storkel, S., Lerman, M. I., Linehan, W. M., and Zbar, B. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet., 16: 68-73, 1997.
63. Halaban, R., Kwon, B. S., Ghosh, S., Delli Bovi, P., and Gaird, A. bFGF as an autocrine growth factor for human melanoma. Oncogene Res., 3: 177-186, 1988.
64. Becker, D., Meier, C. B., and Gerlyn, M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J., 8: 3685-3691, 1989.
65. Becker, D., Lee, P. L., Rodeck, U., and Herlyn, M. Inhibition of the fibroblast growth factor receptor 1 (FGFR-1) gene in human melanocytes and malignant melanomas leads to inhibition of proliferation and signs indicative of differentiation. Oncogene, 7: 3202-3313, 1992.
66. Yayon, A., Ma, Y-S., Safran, M., Klagsburn, M., and Halaban, R. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases. Oncogene, 14: 2999-3009, 1997.
67. Wang, Y., and Becker, D. Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat. Med., 3: 887-893, 1997.
68. Mohammadi, M., Honegger, A. M., Rotin, D., Fishcer, R., Bellot, F., Li, W., Dionne, C. A., Jaye, M., Rubinstein, M., and Schlessinger, J. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol. Cell. Biol., 11: 5068-5078, 1991.
69. Mohammadi, M., Dikic, I., Sorokin, A., Burgess, W. H., Jaye, A., and Schlessinger, J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor I and elucidation of their importance in receptor activation and signal transduction. Mol. Cell. Biol., 16: 977-989, 1996.
70. Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., and Schlessinger, J. A lipid-anchored Grb2-binding protein that links FGF receptor activation to the Ras/MAPK signaling pathway. Cell, 89: 693-702, 1997.
71. Schweppe, R. E., Frazer-Abel, A. A., Guitierrez-Hartmann, A., and Bradford, A. P. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. J. Biol. Chem., 272: 30852-30859, 1997.
72. Faletto, D. L., Kaplan, D. R., Halverson, D. O., Rosen, E. M., and Vande Woude, G. F. Signal transduction in c-met mediated motogenesis. Exper. Suppl. (Basel), 65: 107-130, 1993.
73. Stoker, M., Gherardi, E., Perryman, M., and Gray, J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature (Lond.), 327: 238-242, 1987.
74. Weidner, K. M., Behrens, J., Vandekerckhove, J., and Birchmeier, W. Scatter factor: molecular characteristics and effect on invasiveness of epithelial cells. J. Cell Biol., 111: 2097-2108, 1990.
75. Pepper, M. S., Matsumoto, K., Nakamura, T., Orci, L., and Montesano, R. Hepatocyte growth factor increases urokinase-type plasminogen activator (u-PA) and u-PA receptor expression in Madin-Darby canine kidney epithelial cells. J. Biol. Chem., 267: 20493-20496, 1992.
76. Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. Scatter factor induces blood vessel formation in vivo. Proc. Natl. Acad. Sci. USA, 90: 1937-1941, 1993.
77. Rosen, E. M., Knesel, J., Goldberg, I. D., Jin, L., Bhargava, M., Joseph, A., Zitnik, A., Wines, J., Kelley, M., and Rockwell, S. Scatter factor modulates the metastatic phenotype of the EMT6 mouse mammary tumor. Int. J. Cancer, 57: 706-714, 1994.
78. Jeffers, M., Rong, S., and Vande Woude, G. F. Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth facior/scatter factor-Met signalling in human cells concomitant with induction of the urokinase proteolysis network. Mol. Cell. Biol., 16: 1115-1125, 1996.
79. Royal, I., and Park, M. Hepatocyte growth factor-induced scatter of Madin-Darby canine kidney cells requires phosphatidylinositol 3-kinase. J. Biol. Chem., 270: 27780-27787, 1995.
80. Derman, M. P., Cunha, M. J., Barros, E. J., Nigam, S. K., and Cantley, L. G. HGF-mediated chemotaxis and tubulogenesis require activation of the phosphatidylinositol 3-kinase. Am. J. Physiol., 268: F1211-F1217, 1995.
81. Rahimi, N., Tremblay, E., and Elliott, B. Phosphalidylinositol 3-kinase activity is required for hepatocyte growth factor-induced mitogenic signals in epithelial cells. J. Biol. Chem., 271: 24850-24855, 1996.
82. Besser, D., Bardelli, A., Didichenko, S., Thelen, M., Comoglio, P. M., Ponzetto, C., and Nagamine, Y. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2. Oncogene, 14: 705-711, 1997.
83. Kotelevels, L., Noe, V., Bruyneel, E., Myssiakine, E., Chastre, E., Mareel, M., and Gespach, C. Inhibition by platelet-activating factor of Src-and hepatocyte growth factor-dependent invasiveness of intestinal and kidney epithelial cells. Phosphatidylinositol 3′-kinase is a critical mediator of tumor invasion. J. Biol Chem., 273: 14138-14145, 1998.
84. Giordano, S., Bardelli, A., Zhen, Z., Menard, S., Ponzetto, C., and Comoglio, P. M. A point mutation in the MET oncogene abrogates metastasis without affecting transformation. Proc. Natl. Acad. Sci. USA, 94: 13868-13872, 1997.
85. Bradl, M., Klein-Szanto, A., Porter, S., and Mintz, B. Malignant melanoma in transgenic mice. Proc. Natl. Acad. Sci USA, 88: 164-168, 1991.
86. Herlyn, M., and Shih, I. M. Interactions of melanocytes and melanoma cells with the microenvironment. Pig. Cell Res., 7: 81-88, 1994.
87. Wittbrodt, J., Adam, D., Malitschek, B., Maueler, W., Raulf, F., Telling, A., Robertson, S. M., and Schartl, M. Novel putative receptor tyrosine kinase encoded by the melanoma-induced Tu locus in Xiphophorus. Nature (Lond.), 341: 415-421, 1989.
88. Shartl, M., and Adam, D. Molecular cloning, structural characterization, and analysis of transcription of the melanoma oncogene of Xiphophorus. Pigment Cell Res. (Suppl.), 2: 173-180, 1992.
89. Iwamoto, T., Takahashi, M., Ito, M., Hamatani, K., Ohbayashi, M., Wajjwalku, W., Isobe, K-I., and Nakashima, I. Aberrant melanogenesis and melanocytic tumour development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J., 10: 3167-3175, 1991.
90. Taniguchi, M., Iwamoto, T., Nakashima, I., Nakayama, A., Ohbayashi, M., Matsuyama, M., and Takahashi, M. Establishment and characterization of a malignant melanocytic tumor cell line expressing the ret oncogene. Oncogene, 7: 1491-1496, 1992.
91. Pachnis, V., Mankoo, B., and Costantini, F. Expression of the c-ret proto-oncogene during mouse embryogenesis. Development (Camb.), 119: 1005-1017, 1993.
92. Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., and Pachnis, V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature (Lond.), 367: 380-383, 1994.
93. Easty, D. J., Herlyn, M., and Bennett, D. C. Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis. Int. J. Cancer, 3: 129-136, 1995.
94. Koprowski, H., Herlyn, M., Balaban, G., Parmiter, A. J., Ross, A., and Nowell, P. C. Expression of the receptor for epidermal growth factor correlates with increased dosage of chromosome 7 in malignant melanoma. Somat. Cell Mol. Genet., 11: 297-302, 1985.
95. de Wit, P. E., Moretti, S., Koenders, P. G., Weterman, M. A., van Muijen, G. N., Gianotti, B., and Ruiter, D. J. Increasing epidermal growth factor receptor expression in human melanocytic tumor progression. J. Invest. Dermatol., 99: 168-173, 1992.